Malignant eyelid tumors in Hong Kong 1997–2009

Abstract

Increasing incidence of malignant eyelid tumors was noticed in Hong Kong from 1997 to 2009, with BCC dominating the incidence trend. Recurrence after complete surgical excision was uncommon.

Comparison of the Clinical Characteristics and Outcome of Benign and Malignant Eyelid Tumors: An Analysis of 4521 Eyelid Tumors in a Tertiary Medical Center

“…SGC is very rare in Western literature. However, SGC was the second most common malignant eyelid tumor in our series and accounted for 21.1%, which was similar to some studies in Asia [9, 13–16]. …”

“…BCC is the most common eyelid malignancy worldwide and accounts for 80–95% of all eyelid malignancy [5, 12]. However, in various Chinese studies, the percentage of BCC in all eyelid malignancy was not so much [4, 9, 13, 14]. In our study, BCC remained the most frequently malignant eyelid tumors (57.8%).…”

Declining incidence of eyelid cancers in Singapore over 13 years: population-based data from 1996 to 2008

“…In general, BCC is the most common cancer of the eyelid accounting for about 65% of cases in Taiwan,2 90.8% in Minnesota,4 82.4% in Philadelphia13 and 75% in Hong Kong 14. These are in stark contrast to the proportion of histological diagnosis in India, China and in Japan.…”

Eyelid tumours and pseudotumours in Hong Kong

“…I previously published an article titled "Malignant eyelid tumors in Hong Kong 1997-2009" in an overseas journal back in 2011 focusing on malignant eyelid tumours. 2 While both Ho and I found basal cell carcinoma (BCC) was the most common malignant eyelid tumour among Hong Kong Chinese, BCC constituted 75% of all malignant eyelid tumours as noted from my study in contrast to 43% as reported in Ho's paper.…”